Walmart shares slide as U.S. sales hit by falling drug prices

Walmart reported comparable U.S. sales growth of 2.6% in its second-quarter earnings. The company attributed the slowdown to lower pharmaceutical prices. This marks the lowest comparable sales growth for the retailer in over five years.

Next story